Kennedy Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Kennedy Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,756	Closed	-$1.64M	–	660
2022 Q4	$1.64M	Sell	45,756 -625	-1%	-$15.6K	0.05%	435
2022 Q3	$698K	Sell	46,381 -85	-0.2%	-$1.38K	0.02%	520
2022 Q2	$622K	Sell	46,466 -398	-0.8%	-$6.32K	0.02%	524
2022 Q1	$903K	Sell	46,864 -7,039	-13%	-$146K	0.02%	512
2021 Q4	$1.28M	Sell	53,903 -5,286	-9%	-$122K	0.03%	489
2021 Q3	$1.19M	Buy	+59,189	New	+$1.27M	0.03%	509

Kennedy Capital Management's IMGO Position: Q1 2023 in Review

Kennedy Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 45,756 shares — an estimated $1.64M sold.

Kennedy Capital Management first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $1.64M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Kennedy Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Kennedy Capital Management sold 45,756 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.64M.
Kennedy Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Kennedy Capital Management's Imago BioSciences, Inc. Common stock position peaked at $1.64M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Kennedy Capital Management's 13F filing for Q1 2023, filed 15 May 2023.